Sanofi-Aventis To Work With Chinese Experts In Cancer Stem-Cell Research

SHANGHAI - Sanofi-Aventis will expand its footprint in China by collaborating with Tianjin's Institute of Hematology and Blood Diseases Hospital (IHBDH) in the field of cancer stem cells, the French drug maker announced Sept. 14